Jonathan Heinamann

Founder, CEO and Managing Partner

3 past transactions

BioNTech

Series B in 2019
BioNTech is a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. It contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates.

ComboCap

Private Equity Round in 2017
ComboCap is a technology company with global reach across the pharmaceutical and nutraceutical industries.

Nurevas

Private Equity Round in 2011
Nurevas is a food processing business which is into manufacturing and marketing of a broad range of processed foods.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.